2018 Annual Sessions

SYM21 - SYMPOSIUM 21 - Great Debates in the Management of PAH: Genetics, Bridge to Lung Transplant, and Goal Directed Therapy

Apr 12, 2018 2:00pm ‐ Apr 12, 2018 4:00pm


Description

DEBATE (Pro): Gene vs. Product: Genetic Testing and Not Protemics is the Path Forward to Realize Personalized Management of PAH
Anna Hemnes, MD

DEBATE (Con): Gene vs. Product: Genetic Testing and Not Protemics is the Path Forward to Realize Personalized Management of PAH
Evelyn Horn, MD

Debate Rebuttal (Pro)
Anna Hemnes, MD

Debate Rebuttal (Con)
Evelyn Horn, MD

DEBATE (Pro): Early Application of ECLS is the Preferred Bridge to Lung Transplantation for PAH
Clemens Aigner, MD

DEBATE (Con): Early Application of ECLS is the Preferred Bridge to Lung Transplantation for PAH
Erika  Berman-Rosenzweig

Debate Rebuttal (Pro)
Clemens Aigner, MD

Debate Rebuttal (Con)
Erika  Berman-Rosenzweig

DEBATE (Pro): The ERS/ESC Risk Profiles are Superiorto the REVEAL Calculator for Providing Goal Directed Therapy in PAH
C. Dario Vizza, MD

DEBATE (Con): The ERS/ESC Risk Profiles are Superiorto the REVEAL Calculator for Providing Goal Directed Therapy in PAH
Raymond Benza, MD

Debate Rebuttal (Pro)
C. Dario Vizza, MD

Debate Rebuttal (Con)
Raymond Benza, MD

Speaker(s):

You must be logged in and own this session in order to post comments.